R
5.92
0.12 (2.07%)
| 前收盘价格 | 5.80 |
| 收盘价格 | 5.85 |
| 成交量 | 244,148 |
| 平均成交量 (3个月) | 112,307 |
| 市值 | 274,230,112 |
| 价格/销量 (P/S) | 6.84 |
| 股市价格/股市净资产 (P/B) | 16.33 |
| 52周波幅 | |
| 利润日期 | 12 Nov 2025 |
| 营业毛利率 | -15.10% |
| 营业利益率 (TTM) | -12.92% |
| 稀释每股收益 (EPS TTM) | -0.120 |
| 季度收入增长率 (YOY) | 17.50% |
| 总债务/股东权益 (D/E MRQ) | 22.83% |
| 流动比率 (MRQ) | 2.44 |
| 杠杆自由现金流 (LFCF TTM) | 1.05 M |
| 资产报酬率 (ROA TTM) | -13.09% |
| 股东权益报酬率 (ROE TTM) | -29.87% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 看涨 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 看跌 | |
| 股票 | KORU Medical Systems, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-0.4
| 分析师共识 | 2.0 |
| 内部交易活动 | -3.0 |
| 价格波动 | -4.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 4.0 |
| 平均 | -0.40 |
|
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 7.65% |
| 机构持股比例 | 51.77% |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| MANKO JOSEPH M. JR. | - | 5.80 | -41,000 | -237,800 |
| 累积净数量 | -41,000 | |||
| 累积净值 ($) | -237,800 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 5.80 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| MANKO JOSEPH M. JR. | 董事 | 26 Nov 2025 | 处理 (-) | 41,000 | 5.80 | 237,800 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合